Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Buy Vivus Bullish Options Before Review of Obesity Drug, JPMorgan Advises
Bloomberg
Wednesday, June 23, 2010 - 10:57am
tags:
Vivus, obesity
Biotech Stocks Losing Strength
Minyanville
Wednesday, June 23, 2010 - 10:56am
tags:
biotech, Amgen, Gilead Sciences, Biogen Idec, Merck, Eli Lilly, Pfizer, GSK
Genentech says Lucentis gets new FDA approval
Yahoo/AP
Wednesday, June 23, 2010 - 9:14am
tags:
FDA, Genentech, Lucentis, macular edema
Aetna Confirms It Will Cover Provenge
Minyanville
Wednesday, June 23, 2010 - 9:13am
tags:
Aetna, Provenge, prostate cancer, Dendreon
Glaxo Settles Nearly 200 Paxil Birth Defect Lawsuits
Pharmalot
Wednesday, June 23, 2010 - 9:08am
tags:
Paxil, antidepressants, settlements, lawsuits, birth defects, GSK
What Investors Think About SciClone Pharmaceuticals
Motley Fool
Wednesday, June 23, 2010 - 9:07am
tags:
investors, SciClone
Diabetes And Obesity Options Percolate At JNJ, Novo
Forbes
Wednesday, June 23, 2010 - 9:07am
tags:
obesity, Novo Nordisk, diabetes, JNJ, Ortho-McNeil-Janssen
Biovail and Valeant shares rise to multiyear highs
Yahoo/AP
Wednesday, June 23, 2010 - 9:05am
tags:
Biovail, M&A, Valeant Pharmaceuticals
[video] Glaxo CEO on Global Health Challenges
CNBC
Wednesday, June 23, 2010 - 9:04am
tags:
GSK, Andrew Witty, Pharma CEOs
Is the Big Pharma biotech well going to run dry?
Pharmareform
Wednesday, June 23, 2010 - 8:15am
tags:
biotech, innovation, R&D
Abbott Says It Settled Sandoz Patent Suit Over Biaxin Generic Antibiotic
Bloomberg
Wednesday, June 23, 2010 - 8:14am
tags:
Biaxin, Sandoz, Abbott Laboratories, patents, settlements, antibiotics
Johnson & Johnson CEO to go before the House
Bizjournals.com
Wednesday, June 23, 2010 - 8:10am
tags:
William Weldon, recalls, Pharma CEOs, JNJ
Abbott Laboratories: A Dividend Aristocrat on Sale
Seeking Alpha
Wednesday, June 23, 2010 - 8:09am
tags:
Abbott Laboratories, dividends
A Big Upgrade for DepoMed
Motley Fool
Wednesday, June 23, 2010 - 8:09am
tags:
Depomed
Report: FDA struggles to track foreign drug trials
Yahoo/AP
Wednesday, June 23, 2010 - 8:08am
tags:
FDA, clinical trials
Affymax: Long-Term Value Far From Anemic
Seeking Alpha
Tuesday, June 22, 2010 - 2:52pm
tags:
Affymax
J&J on Hook for "Hundreds of Millions" Over Technicality in Anemia Drug Case
BNET Pharma
Tuesday, June 22, 2010 - 2:49pm
tags:
anemia, JNJ, Procrit, Ortho Biotech
Hospira says FDA clears its generic version of AstraZeneca's IV antibiotic Merrem
Yahoo/AP
Tuesday, June 22, 2010 - 2:47pm
tags:
Hospira, FDA, generics, AstraZeneca, Merrem
Biovail-Valeant combo to claim up to 870 jobs
Fierce Pharma
Tuesday, June 22, 2010 - 2:45pm
tags:
Valeant Pharmaceuticals, M&A, layoffs, Biovail
Amgen's EPO Drugs Dodge a Bullet as Hematide Stumbles, but the Big Biotech's Trials Aren't Over
BNET Pharma
Tuesday, June 22, 2010 - 12:31pm
tags:
Amgen, Hematide, anemia, Affymax, Takeda

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.